Literature DB >> 22190724

Mutational robustness of an RNA virus influences sensitivity to lethal mutagenesis.

Jason D Graci1, Nina F Gnädig, Jessica E Galarraga, Christian Castro, Marco Vignuzzi, Craig E Cameron.   

Abstract

The ability to extinguish a viral population of fixed reproductive capacity by causing small changes in the mutation rate is referred to as lethal mutagenesis and is a corollary of population genetics theory. Here we show that coxsackievirus B3 (CVB3) exhibits reduced mutational robustness relative to poliovirus, manifesting in enhanced sensitivity of CVB3 to lethal mutagens that is dependent on the size of the viral population. We suggest that mutational robustness may be a useful measure of the sensitivity of a virus to lethal mutagenesis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22190724      PMCID: PMC3302263          DOI: 10.1128/JVI.05712-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  Mutation rates among RNA viruses.

Authors:  J W Drake; J J Holland
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

2.  Chemical probing of RNA by nucleotide analog interference mapping.

Authors:  S P Ryder; L Ortoleva-Donnelly; A B Kosek; S A Strobel
Journal:  Methods Enzymol       Date:  2000       Impact factor: 1.600

3.  Poliovirus RNA-dependent RNA polymerase (3D(pol)). Assembly of stable, elongation-competent complexes by using a symmetrical primer-template substrate (sym/sub).

Authors:  J J Arnold; C E Cameron
Journal:  J Biol Chem       Date:  2000-02-25       Impact factor: 5.157

4.  Evolution of digital organisms at high mutation rates leads to survival of the flattest.

Authors:  C O Wilke; J L Wang; C Ofria; R E Lenski; C Adami
Journal:  Nature       Date:  2001-07-19       Impact factor: 49.962

5.  Highly efficient random mutagenesis in transcription-reverse-transcription cycles by a hydrogen bond ambivalent nucleoside 5'-triphosphate analogue: potential candidates for a selective anti-retroviral therapy.

Authors:  K Moriyama; C Otsuka; D Loakes; K Negishi
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2001-08       Impact factor: 1.381

Review 6.  The group B coxsackieviruses and myocarditis.

Authors:  K S Kim; G Hufnagel; N M Chapman; S Tracy
Journal:  Rev Med Virol       Date:  2001 Nov-Dec       Impact factor: 6.989

7.  RNA virus error catastrophe: direct molecular test by using ribavirin.

Authors:  S Crotty; C E Cameron; R Andino
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-22       Impact factor: 11.205

8.  Coxsackievirus infection of the pancreas: evaluation of receptor expression, pathogenesis, and immunopathology.

Authors:  I Mena; C Fischer; J R Gebhard; C M Perry; S Harkins; J L Whitton
Journal:  Virology       Date:  2000-06-05       Impact factor: 3.616

9.  Arbovirus high fidelity variant loses fitness in mosquitoes and mice.

Authors:  Lark L Coffey; Yasnee Beeharry; Antonio V Bordería; Hervé Blanc; Marco Vignuzzi
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-06       Impact factor: 11.205

10.  Synthesis and antiviral evaluation of a mutagenic and non-hydrogen bonding ribonucleoside analogue: 1-beta-D-Ribofuranosyl-3-nitropyrrole.

Authors:  Daniel A Harki; Jason D Graci; Victoria S Korneeva; Saikat Kumar B Ghosh; Zhi Hong; Craig E Cameron; Blake R Peterson
Journal:  Biochemistry       Date:  2002-07-23       Impact factor: 3.162

View more
  28 in total

1.  An Extended Primer Grip of Picornavirus Polymerase Facilitates Sexual RNA Replication Mechanisms.

Authors:  Brian J Kempf; Colleen L Watkins; Olve B Peersen; David J Barton
Journal:  J Virol       Date:  2020-07-30       Impact factor: 5.103

2.  Genomic mutation rates that neutralize adaptive evolution and natural selection.

Authors:  Philip J Gerrish; Alexandre Colato; Paul D Sniegowski
Journal:  J R Soc Interface       Date:  2013-05-29       Impact factor: 4.118

3.  Ribavirin-resistant variants of foot-and-mouth disease virus: the effect of restricted quasispecies diversity on viral virulence.

Authors:  Jianxiong Zeng; Haiwei Wang; Xiaochun Xie; Chen Li; Guohui Zhou; Decheng Yang; Li Yu
Journal:  J Virol       Date:  2014-01-22       Impact factor: 5.103

4.  Structure-function relationships underlying the replication fidelity of viral RNA-dependent RNA polymerases.

Authors:  Grace Campagnola; Seth McDonald; Stéphanie Beaucourt; Marco Vignuzzi; Olve B Peersen
Journal:  J Virol       Date:  2014-10-15       Impact factor: 5.103

5.  Coxsackievirus B3 mutator strains are attenuated in vivo.

Authors:  Nina F Gnädig; Stéphanie Beaucourt; Grace Campagnola; Antonio V Bordería; Marta Sanz-Ramos; Peng Gong; Hervé Blanc; Olve B Peersen; Marco Vignuzzi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-01       Impact factor: 11.205

6.  Structural basis of viral RNA-dependent RNA polymerase catalysis and translocation.

Authors:  Bo Shu; Peng Gong
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-23       Impact factor: 11.205

7.  Attenuation of Foot-and-Mouth Disease Virus by Engineered Viral Polymerase Fidelity.

Authors:  Devendra K Rai; Fayna Diaz-San Segundo; Grace Campagnola; Anna Keith; Elizabeth A Schafer; Anna Kloc; Teresa de Los Santos; Olve Peersen; Elizabeth Rieder
Journal:  J Virol       Date:  2017-07-12       Impact factor: 5.103

8.  Hepatitis A virus adaptation to cellular shutoff is driven by dynamic adjustments of codon usage and results in the selection of populations with altered capsids.

Authors:  M Isabel Costafreda; Francisco J Pérez-Rodriguez; Lucía D'Andrea; Susana Guix; Enric Ribes; Albert Bosch; Rosa M Pintó
Journal:  J Virol       Date:  2014-02-19       Impact factor: 5.103

Review 9.  The role of mutational robustness in RNA virus evolution.

Authors:  Adam S Lauring; Judith Frydman; Raul Andino
Journal:  Nat Rev Microbiol       Date:  2013-03-25       Impact factor: 60.633

10.  Nucleoside analogue mutagenesis of a single-stranded DNA virus: evolution and resistance.

Authors:  Pilar Domingo-Calap; Marianoel Pereira-Gómez; Rafael Sanjuán
Journal:  J Virol       Date:  2012-06-27       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.